Global prevalence of anxiety disorders: a systematic review and meta-regression
- PMID: 22781489
- DOI: 10.1017/S003329171200147X
Global prevalence of anxiety disorders: a systematic review and meta-regression
Abstract
Background: The literature describing the global prevalence of anxiety disorders is highly variable. A systematic review and meta-regression were undertaken to estimate the prevalence of anxiety disorders and to identify factors that may influence these estimates. The findings will inform the new Global Burden of Disease study. Method A systematic review identified prevalence studies of anxiety disorders published between 1980 and 2009. Electronic databases, reference lists, review articles and monographs were searched and experts then contacted to identify missing studies. Substantive and methodological factors associated with inter-study variability were identified through meta-regression analyses and the global prevalence of anxiety disorders was calculated adjusting for study methodology.
Results: The prevalence of anxiety disorders was obtained from 87 studies across 44 countries. Estimates of current prevalence ranged between 0.9% and 28.3% and past-year prevalence between 2.4% and 29.8%. Substantive factors including gender, age, culture, conflict and economic status, and urbanicity accounted for the greatest proportion of variability. Methodological factors in the final multivariate model (prevalence period, number of disorders and diagnostic instrument) explained an additional 13% of variance between studies. The global current prevalence of anxiety disorders adjusted for methodological differences was 7.3% (4.8-10.9%) and ranged from 5.3% (3.5-8.1%) in African cultures to 10.4% (7.0-15.5%) in Euro/Anglo cultures.
Conclusions: Anxiety disorders are common and the substantive and methodological factors identified here explain much of the variability in prevalence estimates. Specific attention should be paid to cultural differences in responses to survey instruments for anxiety disorders.
Similar articles
-
The global burden of anxiety disorders in 2010.Psychol Med. 2014 Aug;44(11):2363-74. doi: 10.1017/S0033291713003243. Epub 2014 Jan 22. Psychol Med. 2014. PMID: 24451993
-
Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.Psychol Med. 2013 Mar;43(3):471-81. doi: 10.1017/S0033291712001511. Epub 2012 Jul 25. Psychol Med. 2013. PMID: 22831756 Review.
-
The regional distribution of anxiety disorders: implications for the Global Burden of Disease Study, 2010.Int J Methods Psychiatr Res. 2014 Dec;23(4):422-38. doi: 10.1002/mpr.1444. Epub 2014 Jul 22. Int J Methods Psychiatr Res. 2014. PMID: 25048296 Free PMC article.
-
Challenging the myth of an "epidemic" of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010.Depress Anxiety. 2014 Jun;31(6):506-16. doi: 10.1002/da.22230. Epub 2014 Jan 21. Depress Anxiety. 2014. PMID: 24448889
-
The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.Int J Epidemiol. 2014 Apr;43(2):476-93. doi: 10.1093/ije/dyu038. Epub 2014 Mar 19. Int J Epidemiol. 2014. PMID: 24648481 Free PMC article. Review.
Cited by
-
Urbanization, loneliness and mental health model - A cross-sectional network analysis with a representative sample.Sci Rep. 2024 Oct 23;14(1):24974. doi: 10.1038/s41598-024-76813-z. Sci Rep. 2024. PMID: 39443642 Free PMC article.
-
Effects of Sleep Quality, Acute Sleep Deprivation, and Napping on Facial Emotion Recognition Accuracy and Speed.Nat Sci Sleep. 2024 Oct 16;16:1637-1651. doi: 10.2147/NSS.S462540. eCollection 2024. Nat Sci Sleep. 2024. PMID: 39430233 Free PMC article.
-
The association between physical activity and anxiety in college students: parallel mediation of life satisfaction and self-efficacy.Front Public Health. 2024 Oct 3;12:1453892. doi: 10.3389/fpubh.2024.1453892. eCollection 2024. Front Public Health. 2024. PMID: 39421812 Free PMC article.
-
Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol.J Cannabis Res. 2024 Oct 12;6(1):40. doi: 10.1186/s42238-024-00250-y. J Cannabis Res. 2024. PMID: 39394179 Free PMC article. Review.
-
Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders.Front Med (Lausanne). 2024 Sep 19;11:1463976. doi: 10.3389/fmed.2024.1463976. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39364023 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous